×
Home
Archive Submission Guidelines
News Contact
Review article
Crossmark

Skin challenges in COVID-19 pandemic: The importance of cosmeceuticals

By
Marija Tasić-Kostov Orcid logo
Marija Tasić-Kostov

University of Nis , Niš , Serbia

Abstract

Although COVID-19 is present in a milder form nowadays, systemic disorders caused by the virus lead to multiple organ malfunctions. Skin manifestations are the consequence of the disease itself but also the result of preventative measures taken to avoid the infection. They generally do not require pharmacotherapy except in severe cases. Depending on the severity of COVID-19-related skin disorder, cosmeceuticals are often recommended in their management. In this study, we highlighted skin adverse events related to all aspects of COVID-19 pandemic aiming to provide a comprehensive overview and enlighten the role of cosmeceuticals in the treatment of those skin issues, according to published studies and guidelines. Different steps were conducted in preparation of this review-identification of all factors that affect skin in pandemics (protective measures, disease itself, post-COVID syndrome), selection and classification of reported skin symptoms which could be managed using cosmeceuticals, according to relevant papers and guidelines. Skin challenges in COVID-19 pandemics could be divided into three main categories: 1) Cutaneous manifestations of COVID-19 disease; 2) Cutaneous symptoms as a result of wearing protective equipment and using disinfectants, and 3) Cutaneous symptoms related to the post COVID-19 syndrome. Cosmeceuticals, a unique category of products between cosmetics and pharmaceuticals, are highly recommended in literature for the management of the aforesaid changes except in severe skin disorders. Since the introduction of cosmeceutical concept, those topicals have become an extremely important part of dermatologist's armamentarium. COVID-19 pandemic confirms their importance.

References

1.
Kim J, Yoo S, Kwon OS, Jeong ET, Lim JM, Park SG. Influence of quarantine mask use on skin characteristics: One of the changes in our life caused by the COVID‐19 pandemic. Skin Research and Technology. 2021;27(4):599–606.
2.
Rogers NE. Cosmeceuticals for Hair Loss and Hair Care. Cosmeceuticals and Cosmetic Practice. 2013. p. 234–44.
3.
McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. The Lancet Infectious Diseases. 2021;21(3):313–4.
4.
Müller‐Ramos P, Ianhez M, Silva de Castro CC, Talhari C, Criado PR, Amante Miot H. Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients. International Journal of Dermatology. 2022;61(5).
5.
Diotallevi F, Mazzanti S, Properzi P, Olivieri S, Giacometti A, Offidani A. Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre. Journal of the European Academy of Dermatology and Venereology. 2022;36(3).

Citation

Article metrics

Google scholar: See link

Citations

Crossref Logo

1

Crossref Logo

Se Jin Chung, So Young Sohn, Yurim Kim, Se Yeon Jun, Geon Hyeok Chun

(2026)

Multiplex Network-Based Prediction for Technological Convergence and Its Application to Firm-Level Strategies for the Post-Pandemic Cosmetics Industry

IEEE Access, 14()

10.1109/ACCESS.2026.3677300

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.